Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
because rigorously controlled human safety data specific to the TB-500 fragment does not exist, its longer-term risk profile, including possible immune reactions, remains unknown Evidence snapshot: Evidence for TB-500 itself is preclinical, drawn mainly from cell-culture and animal studies (a 1999 rat wound-healing study and later rodent cardiac- and tendon-injury models), with a 2026 scoping review describing the musculoskeletal literature on thymosin beta-4 and TB-500 as sparse and largely preclinical
Other benefits of this treatment include: Protect Bone Health As we grow older, we are all at higher risk of bone disease such as osteopenia, which is a condition that makes your bones more fragile as you age
You can protect the peptide with a gentle flow of liquid instead of a strong force
Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease
If you add this and still find yourself burping up your fish oil
W., & Larsen, S
